Cautionary Advisory Labels (CALs) are applied in addition to the dispensed label at the point of dispensing. The colour and design are intended to...
In the pilot phase of the The national Take Home Naloxone (THN) program, ‘three lives were saved each day’, and it is expected that an even greater impact will be seen with the national rollout.
A patient inquiry about ocular changes may provide pharmacists with an opportunity to screen or refer patients to an optometrist.
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
Over-reliance on urine dipstick testing to guide urinary tract infection management contributes to antibiotic overuse and misuse.
A popular wonder drug of the 19th century, this patent medicine packed multiple punches.
In 1848, Dr John Collis Browne had a problem. After training...
Sarsparilla comes in teas, tablets, tinctures, and capsules. While use is widespread, evidence of its medical effectiveness is limited.
This summary will present the most up to date findings from a recent Cochrane review.1
Background
It is estimated that a total of 2.8 million people...
It comes in teas, tablets, tinctures, and capsules, and may only look good.
In colonial Australia sarsaparilla was a hit. Like their American counterparts the...
How pharmacists can improve the lives of people living with disabilities through careful medicine reviews and follow-up.
Just like medicine safety challenges in aged care,...
